Book Online or Call 1-855-SAUSALITO
Sign In \| Register \| About Sausalito \| Contact Us
Sausalito, CA September 01, 2020 1:41pm 7-Day Forecast \| Traffic

- Apartments

Search Hotels in Sausalito
CHECK-IN:
CHECK-OUT:
ROOMS:

Find A Business
or Browse Listings

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Myriad Genetics, Inc. - Common Stock (NQ:MYGN)

7.735 -0.175 (-2.21%)

Streaming Delayed Price Updated: 11:41 AM EST, Nov 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Myriad Genetics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health

November 25, 2025

Actionable offering helps enable earlier, more personalized breast cancer interventions

From Myriad Genetics, Inc.

Via GlobeNewswire

Myriad Genetics, Neogen, ICU Medical, HCA Healthcare, and Universal Health Services Stocks Trade Up, What You Need To Know

November 24, 2025

A number of stocks jumped in the afternoon session after reports revealed the Trump administration considered extending the Affordable Care Act (ACA) subsidies. These subsidies, which are government...

Via StockStory

Topics Economy Government

Earnings Scheduled For November 3, 2025 ↗

November 03, 2025

Via Benzinga

Insulet, Guardant Health, agilon health, Evolent Health, and Myriad Genetics Stocks Trade Up, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Economy

Why Myriad Genetics (MYGN) Stock Is Up Today

November 19, 2025

Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 0.4% in the afternoon session after the company shared a positive outlook, projecting significant revenue from its hereditary...

Via StockStory

Topics Artificial Intelligence Stocks

Q3 Earnings Roundup: Myriad Genetics (NASDAQ:MYGN) And The Rest Of The Therapeutics Segment

November 18, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Myriad Genetics (NASDAQ:MYGN) and its peers.

Via StockStory

Topics Artificial Intelligence

1 High-Flying Stock with Solid Fundamentals and 2 We Question

November 13, 2025

Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices,...

Via StockStory

Topics Artificial Intelligence Economy

Merck, Elanco, Myriad Genetics, Neogen, and Cigna Shares Are Soaring, What You Need To Know

November 11, 2025

A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid...

Via StockStory

Topics Artificial Intelligence Stocks

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

November 11, 2025

From Myriad Genetics, Inc.

Via GlobeNewswire

Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to Support Evolving Clinical Needs

November 10, 2025

100% of genes strongly recommended by national oncology guidelines are included in the MyRisk Test

From Myriad Genetics, Inc.

Via GlobeNewswire

The Top 5 Analyst Questions From Myriad Genetics’s Q3 Earnings Call

November 10, 2025

Myriad Genetics’ third quarter saw revenue and adjusted profit in line with Wall Street expectations, but the market reacted negatively due to ongoing challenges in average revenue per test and...

Via StockStory

Topics Earnings

Myriad Genetics to Highlight Genetic Testing Advancements at 2025 National Society of Genetic Counselors Annual Conference

November 06, 2025

From Myriad Genetics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 04, 2025

Via Benzinga

Why Myriad Genetics (MYGN) Stock Is Down Today

November 04, 2025

Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) fell 19.3% in the morning session after it reported mixed third-quarter results that were overshadowed by a weak earnings outlook.

Via StockStory

Topics Economy Government World Trade

MYGN Q3 Deep Dive: Oncology Growth and Product Launches Offset Market Headwinds

November 04, 2025

Genetic testing company Myriad Genetics (NASDAQ:MYGN) met Wall Streets revenue expectations in Q3 CY2025, but sales fell by 3.6% year on year to $205.7 million. The company’s outlook for the full year...

Via StockStory

Myriad Genetics’s (NASDAQ:MYGN) Q3 Earnings Results: Revenue In Line With Expectations But Stock Drops

November 03, 2025

Via StockStory

Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution

November 03, 2025

From Myriad Genetics, Inc.

Via GlobeNewswire

What To Expect From Myriad Genetics’s (MYGN) Q3 Earnings

November 01, 2025

Genetic testing company Myriad Genetics (NASDAQ:MYGN) will be reporting results this Monday after the bell. Here’s what to expect.

Via StockStory

Exploring Myriad Genetics's Earnings Expectations ↗

October 31, 2025

Via Benzinga

New Post-Hoc Analysis Shows Patients Whose Clinicians Had Access to GeneSight Results for Depression Treatment Are More Likely to Feel Better Sooner

October 31, 2025

Faster initial remission and response, persistent benefit over six months

From Myriad Genetics, Inc.

Via GlobeNewswire

1 Stock Under $10 Worth Your Attention and 2 Facing Challenges

October 30, 2025

Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums). That doesn’t mean they’re bargains though, and we urge investors to be...

Via StockStory

Myriad Genetics to Release Third Quarter 2025 Financial Results on November 3, 2025

October 27, 2025

From Myriad Genetics, Inc.

Via GlobeNewswire

October 17, 2025

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can...

Via StockStory

Myriad Genetics Adds F8, FXN Genes to Foresight Universal Plus Panel

October 14, 2025

The Foresight® Carrier Screen includes all conditions recommended by the American College of Medical Genetics and Genomics recommendations

From Myriad Genetics, Inc.

Via GlobeNewswire

3 Cash-Burning Stocks with Open Questions

October 14, 2025

While some companies burn cash to fuel expansion, others struggle to turn spending into sustainable growth. A high cash burn rate without a strong balance sheet can leave investors exposed to...

Via StockStory

Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Via StockStory

Topics Economy Government World Trade

Breast Cancer Awareness Month: Patient and Clinician Share Insights on how to tackle the fear of cancer screenings on YourUpdateTV

October 08, 2025

From D S Simon

Via GlobeNewswire

A Look Back at Therapeutics Stocks’ Q2 Earnings: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Pack

October 01, 2025

Looking back on therapeutics stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Myriad Genetics (NASDAQ:MYGN) and its peers.

Via StockStory

Topics Artificial Intelligence

3 Unprofitable Stocks That Fall Short

September 30, 2025

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.

Via StockStory

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

September 23, 2025

From Myriad Genetics, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Search Hotels in Sausalito

Find A Business

or Browse Listings

Myriad Genetics, Inc. - Common Stock (NQ:MYGN)

All News about Myriad Genetics, Inc. - Common Stock